41st week of 2008 patent applcation highlights part 32 |
Patent application number | Title | Published |
20080247901 | Carburized and high-frequency hardened part having high strength - The present invention relates to a mechanical part, which is obtained by: processing a steel into a shape of a part, the steel having an alloy composition containing, by weight percent, C: 0.10 to 0.30%, Si: 0.50 to 3.00%, Mn: 0.30 to 3.00%, P: 0.030% or less, S: 0.030% or less, Cu: 0.01 to 1.00%, Ni: 0.01 to 3.00%, Cr: 0.20 to 1.00%, Al: 0.20% or less, N: 0.05% or less, and the remainder of Fe and inevitable impurities, and the alloy composition satisfying the following condition: | 2008-10-09 |
20080247902 | High-Strength, Lightweight Austenitic-Martensitic Steel and the Use Thereof - The invention relates to a high-strength, lightweight austenitic-martensitic steel and the use thereof. The inventive lightweight steel is characterized by a chrome content of more than 0.5% and less than 18%, a silicon content of more than 1% and less than 4%, a manganese content of more than 2.5% and less than 30% and an aluminum content of more than 0.05 to 4% and lies within an alloy range that is determined by the coordinates of four points (Cr | 2008-10-09 |
20080247903 | Method for Making an Abrasion-Resistant Steel Plate and Plate Obtained - The invention concerns a method for making an abrasion resistant steel plate having a chemical composition comprising: 0.35%≦C≦0.8%, 0%≦Si≦2%, 0%≦Al≦2%, 0.35%≦Si+Al≦2%, 0%≦Mn≦2.5%, 0%≦Ni≦5%, 0%≦Cr≦5%, 0%≦Mo≦0.50%, 0%≦W≦1.00%, 0.1%≦Mo+W/2≦0.50%, 0%≦B≦0.02%, 0%≦Ti≦2%, 0%≦Zr≦4%, 0.05%≦Ti+Zr/2≦2%, 0%≦S≦0.15%, N≦0.03%; optionally from 0% to 1.5% of Cu; optionally Nb, Ta or V with Nb/2+Ta/4+V≦0.5%; optionally less than 0.1% of Se, Te, Ca, Bi or Pb; the rest being iron and impurities; the composition satisfying: 0.1%≦C*=C−Ti/4−Zr/8+7×N/8≦0.55% and 1.05×Mn+0.54×Ni+0.5O×Cr+0.3×(Mo+W/2) | 2008-10-09 |
20080247904 | RF plasma system for medical waste treatment - A system and method are provided for the thermal and non-thermal (oxidation) plasma treatment of medical waste using an electrode-less induction (thermal) and capacitive (non-thermal) plasma torches. The medical waste is pre-treated by liquid nitrogen, crushed and pulverized by LN2 crusher/pulverizer, and conveyed to the nitrogen/water thermal plasma reactor, which converts the powdered medical waste into carbon black and generated gas (resulting from the thermal step) is directed to the Oxygen non-thermal plasma reactor for post-treatment. The system is equipped with an emission control unit, dual frequency pulse RF power supply, and Liquid Nitrogen Generator. The off gas from LN2 crusher (nitrogen) is used for the induction plasma torch and off gas from LN2 generator (oxygen) is used as a plasma gas for the Non-thermal plasma torch. | 2008-10-09 |
20080247905 | Microparticles with enhanced covalent binding capacity and their uses - Disclosed are proteins which are covalently bound to a solid support at a first temperature where they have a first configuration, and then biomolecules are attached to the bound proteins at a higher temperature at which the proteins have more exposed functional groups, each such group being capable of covalently bonding to a biomolecule. The biomolecule can be, for example, a nucleic acid, e.g., an amine functionalized oligonucleotide. The proteins can include, e.g., BSA (Bovine Serum Albumin) which can be bound using a reaction with the surface of a tosyl-activated microparticle. | 2008-10-09 |
20080247906 | Luminescence Sensor for Determining and/or Monitoring an Analyte that is Contained in a Fluidic Process Medium - A device for determining and/or monitoring an analyte contained in a fluidic process medium. The device comprises a sensor, which contains a process membrane with a porous support structure, a luminescent substance, that comes into contact with the analyte or gaseous process medium, being embedded in said support structure, an emitter unit, whose radiation excites the luminescent substance, causing it to emit luminescent radiation, a receiver unit, which detects the luminescent radiation and a control/evaluation unit, which determines the concentration or the partial pressure or pressure of the analyte using the quenching of the luminescent radiation of the luminescent substance. According to the invention, the porous support structure comprises plastic, ceramic, metal or foamed plastic. | 2008-10-09 |
20080247907 | Dual inlet microchannel device and method for using same - A dual inlet microchannel device and a method for using the device to perform a flow-through kinetic assay are described. A microplate having an array of the dual inlet microchannel devices and in particular their specially configured flow chambers is also described. Several embodiments of the dual inlet microchannel devices and specially configured flow chambers are also described. | 2008-10-09 |
20080247908 | Sensor Chip for a Biosensor - The invention relates to a microchip ( | 2008-10-09 |
20080247909 | Sample suction apparatus - A sample suction apparatus includes: first through third members; a drive source; and a suction needle provided on the third member. The drive source reduces a distance between the first member and the third member to perform: a first action of shifting the first member toward the third member to contact the first member with a portion of a specimen vessel; a second action of shifting the second member together with the third member toward the first member to contact the second member with another portion of the specimen vessel so that the specimen vessel is sandwiched between the first and second members; and a third action of shifting the third member toward the first member to bring the third member close to the second member so that the suction needle is inserted in the specimen vessel. | 2008-10-09 |
20080247910 | Device for Testing a Fluid | 2008-10-09 |
20080247911 | Measurement of Concentrations and Binding Energetics - Free-standing microfluidic channels are used to both transport and analyze molecules of interest. In a biochemical context, such molecules may be polypeptides, nucleic acids, or other biomolecules. The free-standing channels provide a real-time readout of concentration without the need for labeling with reporter molecules. The channels can also measure enthalpy values and equilibrium constants by detecting heat released from or absorbed by the sample. | 2008-10-09 |
20080247912 | Urea Concentration Identification Device for Urea Solution - A urea concentration identification device comprising a concentration identification sensor unit ( | 2008-10-09 |
20080247913 | Suction Device - This invention relates to plunger operated liquid dispensers, such as hand held pipettors, which are used to portion liquids. Specifically the invention relates to a reliable removal of a liquid from the liquid dispenser. According to the invention the plunger of the liquid dispenser is arranged into a speeded up movement while removing the liquid. This change in speed is preferably sudden. | 2008-10-09 |
20080247914 | Sample Preparation System And Method for Processing Clinical Specimens - A system and method for automated handling of vials containing liquid medical specimens is disclosed. The robotic system processes the specimens for further downstream molecular analysis. The processing comprises automated vial cap removal, pipetting of the vial contents, transfer of the vial contents to a destination tray such as a multiwell plate, and recapping of the vial. | 2008-10-09 |
20080247915 | Apparatus for the preparation of mammalian specimens for cryopreservation and/or vitrification, and for thawing and using susch specimens - A biological specimen processing dish assembly includes a dish portion for use in treating specimens such as oocytes, embryos, tissues, and the like sequientially with different reagents or media. The dish includes a plurality of geometrically arranged wells disposed in related sets. The wells are operative to receive reagents or media for the use in treatment of the specimens in question. The specimens can be subjected to a sequence of different treatment media in the wells in a set thereof so as to provide a coherant device for subjecting specimens to a treatment procedure that requires the specimens to be subjected to different media or reagents during sequencial steps in the treatment protocol. The dish can be partially filled with a layer of oil that overlies the reagents in the wells and protects the specimens from exposure to air during the treatment protocol. The dish can be provided with an internal partition that segments the dish so as to provide a plurality of wells that will not be covered by the oil layer. The assembly can also include a cover for overlying the dish so as to provide areas where protocol information can be displayed to enable the technician to properly use the dish assembly in performance of the treatment protocols. | 2008-10-09 |
20080247916 | REACTION APPARATUS AND REACTION CHIP - A reaction apparatus is provided with a reaction chip ( | 2008-10-09 |
20080247917 | Catalyst for Removing Nitrogen Oxidase - The present invention is to provide a catalyst for removing nitrogen oxides which is capable of keeping sufficient denitrification performance, i.e., a high removal rate of nitrogen oxides in exhaust gas having a high NO | 2008-10-09 |
20080247918 | HONEYCOMB FILTER, EXHAUST GAS PURIFYING APPARATUS, AND METHOD FOR MANUFACTURING HONEYCOMB FILTER - A honeycomb filter includes a pillar-shaped honeycomb fired body having a large number of cells each sealed at either end thereof and placed longitudinally in parallel with one another with a cell wall therebetween. A sum of cross-sectional areas perpendicular to a longitudinal direction of cells having openings on a gas inlet side is about 1.5 to about 3.0 times larger than a sum of cross-sectional areas of cells having openings on a gas outlet side. A catalyst supporting layer is formed in a catalyst-supporting-layer area covering about 25 to about 90% of an overall length of the honeycomb filter, and substantially no catalyst supporting layer is formed in a non-catalyst-supporting-layer area covering about 10% of the overall length of the honeycomb filter. The non-catalyst-supporting-layer area abuts the gas outlet side. A thermal conductivity of the non-catalyst-supporting-layer area is higher than a thermal conductivity of the catalyst-supporting-layer area. | 2008-10-09 |
20080247919 | Calibrated Catalyst Carrier Body with Corrugated Casing - A method for manufacturing a catalyst carrier body includes producing a honeycomb body having at least partially structured layers forming channels through which a fluid can flow. The honeycomb body has an external extent formed at least partially by ends of the layers. At least one corrugated casing and a housing are also produced. The honeycomb body is inserted into the corrugated casing and the corrugated casing with the honeycomb body is inserted into the housing with the housing at least partially surrounding the honeycomb body. The housing is calibrated by reducing at least an internal contour of the housing and preferably also a profile of the corrugated casing. The honeycomb body is connected to the housing with the corrugated casing disposed between the honeycomb body and the housing. A catalyst carrier body produced by the method is also provided. | 2008-10-09 |
20080247920 | Apparatus for Manipulating Droplets - An apparatus for manipulating droplets is provided. In one embodiment, the apparatus includes a substrate having electrodes and adjacent reference elements configured for manipulating a droplet on a surface of the substrate. Other embodiments having a top plate, a footprint, and a dielectric are also included. | 2008-10-09 |
20080247921 | Synergistic corrosion management systems for controlling, eliminating and/or managing corrosion - The present invention generally relates to synergistic corrosion management systems designed to deliver two or more different types of corrosion inhibiting compounds (e.g., two or more different types of corrosion inhibiting compounds) to an enclosure, and to method for using same. More specifically, the present invention relates to synergistic corrosion management systems designed to eliminate, manage, control and/or mitigate corrosion in containers, enclosures, cisterns and/or storage tanks (e.g., above ground storage tanks). In one embodiment, the present invention utilizes a combination of at least one cathodic-based corrosion prevention or mitigation system, at least one soluble corrosion inhibitor, and at least one volatile or vapor phase corrosion inhibitor. In another embodiment, the present invention utilizes a combination of at least one cathodic corrosion prevention or mitigation system, at least one soluble corrosion inhibitor, and at least one volatile or vapor phase corrosion inhibitor to control, mitigate and/or eliminate corrosion in the bottom portions of above ground storage tanks. | 2008-10-09 |
20080247922 | METHODS AND APPARATUS FOR DECONTAMINATING ENCLOSED SPACES - A portable apparatus for decontaminating an enclosed room or other space includes a passageway having an air inlet at one end and an outlet at the other end. A pump causes a flow of air through the passageway from the inlet to the outlet. A heater heats the air flowing through the passageway to a predetermined temperature, a evaporator being in communication with the passageway. Liquid decontaminant is pumped from a supply of decontaminant to the evaporator to be evaporated and for the evaporant to be delivered to the air flow in the passage to flow in the air flow from the outlet to the rooms to be decontaminated. A universally rotating nozzle is provided at the outlet to distribute the decontaminant containing air throughout the enclosure. | 2008-10-09 |
20080247923 | Plate Design for Mixer Sparger - An apparatus is disclosed for the generation of hydrogen peroxide. The apparatus is designed to allow for a greater range of tolerances in its manufacture. The apparatus provides for the production of a large scale volume of hydrogen peroxide by the generation of a liquid bearing bubble cloud. The bubbles are generated with a tiny volume before flowing over the reactor bed to generate the hydrogen peroxide. | 2008-10-09 |
20080247924 | POU COLD TANK STERILIZING SYSTEM - Disclosed is a a POU (point of use) cold tank sterilizing system which is a POU cold tank sterilizing system, mainly used for POU coolers used at home or office. With a cold tank and a hot tank are on the same water level and connected to each other | 2008-10-09 |
20080247925 | SEPARATION AND RECOVERY OF PRECIOUS METALS USING POLYMER MATERIALS - A method of separation and/or recovery of a precious metal from a solution containing said precious metal in ionic form, optionally in the presence of impurities, including the step of contacting a solution containing said precious metal in ionic form with a conducting polymer. The method is generally applicable to precious metals including platinum (Pt), palladium (Pd) and more particularly gold (Au). The ionic species may be anionic (for example [AuCl.sub.4].sup.-) or cationic. The polymer may be for example, a polypyrrole or polythiophene, optionally doped and are preferably in a high surface area form eg. coated onto cloth or RVC or in self supporting colloidal form. The polymer may also contain species to give further functionality, eg magnetic or heat sensitive species. | 2008-10-09 |
20080247926 | CATALYTIC PEROXIDE OXYGEN GENERATOR-CONCENTRATOR - A method for generating concentrated oxygen at elevated pressure comprising the steps of (a) injecting a molecular oxygen precursor into a pressurized reaction vessel; (b) contacting the molecular oxygen precursor within a reaction vessel with a catalyst to cause the molecular oxygen precursor to decompose to liquid water and gaseous reaction products, the gaseous reaction products including a gaseous condensible moiety and a gaseous non-condensible moiety, the gaseous non-condensible moiety containing molecular oxygen the concentration of which is C | 2008-10-09 |
20080247927 | Ammonia Destruction Methods for Use in a Claus Tail Gas Treating Unit - Oxidative and reductive methods are described for the cost-effective destruction of an ammonia-bearing gas stream, potentially containing minor but significant quantities of hydrogen sulfide (H | 2008-10-09 |
20080247928 | Method of Removing Nitrous Oxide - Hydroxylamine is formed in a reactor through a partial hydrogenation of nitric oxide gas (NO) with hydrogen gas (H | 2008-10-09 |
20080247929 | HIGH ACTIVITY TITANIA SUPPORTED METAL OXIDE DeNOx CATALYSTS - The present invention is directed to high activity titanium oxide DeNOx catalysts. In preferred embodinents, by depositing vanadium oxide on a titania supported metal oxide such as tungsten oxide, an improved catalyst may be generated. This catalyst may be used in the treatment of exhaust from sources such as automobiles and industrial plants. | 2008-10-09 |
20080247930 | Nano-fusion reaction - A nano-fusion reactor comprised of nano-particles such as carbon based nanotubes, endohedral fullerenes and other nano materials encapsulating fusible fuels such as the hydrogen isotopes, deuterium, and tritium. The nano-devices encapsulate the fusible materials and ignite fusion reactions which in some of the embodiments consume the nano-fusion reactor device requiring the replenishment of these devices so to continue the fusible reactions. The reactions can be controlled and scaled through modulated presentation of fusion targets to the ignition chamber. The fusion reactions are ignited in the embodiments through one or more of the applied forces in the fusion reactor: electromagnetic compressive, electrostatic, and thermo. These applied forces in conjunction with the extreme structural strength, the ablation forces and purity of the nano-fusion device produces maximum forces necessary for the production of a shock wave on the nano-encapsulated device to ignite one or a plurality of fusion reactions. The lower ignition energy is due to a smaller device with less fuel, more efficient coupling of applied energy by the nano-device, along with purer encapsulated fuels, and improved geometries has provided improvements over conventional ICF reactions. | 2008-10-09 |
20080247931 | Method for Producing Multi-Constituent, Metal Oxide Compounds Containing Alkali Metals,and thus Produced Metal Oxide Compounds - The preparation of finely divided, alkali metal-containing metal oxide powders which contain at least one alkali metal and at least one further metal from the group consisting of the transition metals, the remaining main group metals, the lanthanides and actinides is described. Precursor compounds of these components are introduced in solid form or in the form of a solution or a suspension into a pulsation reactor having a gas flow resulting from a flameless combustion and partly or completely converted into the desired multicomponent metal oxide powder. | 2008-10-09 |
20080247932 | Method for making colloidal nanocrystals - A method for making colloidal nanocrystals includes the following steps: dissolving a nanocrystal powder in an organic solvent, and achieving a solution A of a concentration of 1-30 mg/ml; dissolving a surfactant in water, and achieving a solution B of a concentration of 0.002-0.05 mmol/ml; mixing the solution A and the solution B in a volume ratio of 1: (5-30), and achieving a mixture; stirring and emulsifying the mixture, until an emulsion C is achieved; removing the organic solvent from the emulsion C, and achieving a deposit; then washing the deposit with deionized water, and achieving colloidal nanocrystals. The present method for making colloidal nanocrystals is economical and timesaving, and has a low toxicity associated therewith. Thus, the method is suitable for industrial mass production. The colloidal nanocrystals made by the present method have a readily controllable size, a narrow size distribution, and good configuration. | 2008-10-09 |
20080247933 | INORGANIC PIGMENTS AND PROCESS FOR PREPARING SAME - The present invention provides yellow inorganic pigments comprising praseodymium, oxides of transition metals selected from molybdenum, titanium, zirconium and combinations thereof, essentially molybdenum, optionally with alkaline earth metal (A) and the said yellow inorganic pigment has a general formula APr | 2008-10-09 |
20080247934 | WHITE LIGHT EMITTING DIODE COMPONENT HAVING TWO PHOSPHORS AND RELATED PHOSPHOR AND FORMATION METHOD - A white light emitting diode component capable of emitting white light includes an LED chip capable of emitting luminescent light, a first phosphor for absorbing first luminescent light of the luminescent light and emitting first emission, and a second phosphor for absorbing second luminescent light of the luminescent light and emitting second emission. A blend of the luminescent light (except for the first and the second luminescent light) and the first and the second emissions forms the white light. The first phosphor has a chemical formula of (Ca | 2008-10-09 |
20080247935 | Compound Semiconductor Substrate - It is to provide a substrate for epitaxial growth, which is capable of improving a surface state of an epitaxial layer at microroughness level. In a substrate for epitaxial growth, when haze is defined as a value calculated by dividing intensity of scattered light obtained when light is incident from a predetermined light source onto a surface of a substrate, by intensity of the incident light from the light source, the haze is not more than 2 ppm all over an effectively used area of the substrate and an off-angle with respect to a plane direction is 0.05 to 0.10°. | 2008-10-09 |
20080247936 | Method For Producing High Purity Silicon - An object of the present invention is to provide a method for producing a great deal of inexpensive high purity silicon useful in a solar battery. Disclosed is a method for producing the high purity silicon by migrating impurities in molten silicon to slag including the step of feeding an oxidizing agent to the molten silicon together with slag, wherein the oxidizing agent is a material comprising as a primary component at least one of the following materials: alkali metal carbonate, hydrate of alkali metal carbonate, alkali metal hydroxide, alkaline-earth metal carbonate, hydrate of alkaline-earth metal carbonate or alkaline-earth metal hydroxide. | 2008-10-09 |
20080247937 | Carbonate and method for producing the same - To provide a method for producing a carbonate, including: growing seed crystals, wherein the seed crystals are grown in a reaction solution containing at least urea. An aspect in which the seed crystals are strontium carbonate particles, an aspect in which the reaction solution contains a metal ion source and the metal ion source is a hydroxide of strontium, and the like are favorable. | 2008-10-09 |
20080247938 | Process of growing carbon nanotubes directly on carbon fiber - A process for growing a carbon nanotube directly on a carbon fiber includes at least the steps of depositing a metallic film of at least 1 nm in thickness on at least one surface of a flake-shaped carbon-fiber substrate; placing the substrate into a reactor; introducing a gas including carbon-containing substances into the reactor as a carbon source needed for growing a plurality of carbon nanotubes (CNTs); and thermally cracking the carbon-containing substances in the gas to grow the carbon nanotubes directly on the substrate. | 2008-10-09 |
20080247939 | Process for Producing Carbon Nanotubes - The invention provides a process for producing carbon nanotubes which includes supplying a continuous fluidized feed of a catalyst and at least one hydrocarbon to a reactor operating under conditions suitable to produce carbon nanotubes. The fluid is made to flow though the reactor with a swirling motion which ensures that the internal surfaces of the reactor are cleaned of deposits. | 2008-10-09 |
20080247940 | Carbon Black Coloring Agent for Semiconductor Sealing Material and Method of Manufacturing the Same - The present invention provides a carbon black coloring agent suitable as a black coloring agent for a semiconductor sealing material, exhibiting excellent dispersibility in a resin component, and capable of forming a semiconductor sealing material having a high volume resistivity and excellent shading properties, and a method of manufacturing the same. The carbon black coloring agent has a structure in which terminal hydrogen of a carboxyl group formed on the surface of a carbon black particle by wet oxidation using sodium persulfate or ammonium persulfate is replaced by ammonia, and has a pH of 3.0 to 8.0. The method includes subjecting carbon black to wet oxidation in a sodium persulfate aqueous solution or an ammonium persulfate aqueous solution, removing reducing salts by deionization, adding an ammonia aqueous solution reaction to adjust the pH of the slurry to 4.0 to 12.0, causing the carbon black to react with ammonia, purifying the slurry by removing foreign matter from the slurry, and drying and grinding the carbon black. It is preferable to subject the carbon black to dry oxidation in advance before wet oxidation and to add a surfactant when subjecting the carbon black to wet oxidation. | 2008-10-09 |
20080247941 | Mechanically Stable Catalyst Based on Alpha-Alumina - A catalyst for gas-phase reactions which has high mechanical stability and comprises one or more active metals on a support comprising aluminum oxide as support material, wherein the aluminum oxide in the support consists essentially of alpha-aluminum oxide. | 2008-10-09 |
20080247942 | Method and Reactor for Carrying Out Endothermic Catalytic Reactions - A method and device for the endothermic catalytic reaction of a supply flow is disclosed. The supply flow is divided into at least two partial flows that are parallelly guided through reactor tubes, which are situated inside the combustion chamber of a reactor and which are at least partially filled with a catalyst material or of a catalytically active structured packing or the interior thereof is at least partially surface-coated with a catalytically active material. The partial flows are guided inside a number of passages in the reactor tubes through the combustion chamber inside of which suitable burners guarantee an intense circulation of the combustion chamber atmosphere. | 2008-10-09 |
20080247943 | Blood Clot-Targeted Nanoparticles - Emulsions comprising nanoparticles formed from high boiling perfluorochemical substances, said particles coated with a lipid/surfactant coating are made target-specific by directly coupling said nanoparticles to a targeting ligand. The nanoparticle may further include biologically active agents, radionuclides, and/or other imaging agents, and are used to image and/or lyse blood clots in human subjects. | 2008-10-09 |
20080247944 | Irta-2 Antibodies and Their Uses - The present invention provides isolated monoclonal antibodies, particularly human monoclonal antibodies, that specifically bind to IRTA-2 with high affinity. Nucleic acid molecules encoding the antibodies of the invention, expression vectors, host cells and methods for expressing the antibodies of the invention are also provided. Immunoconjugates, bispecific molecules and pharmaceutical compositions comprising the antibodies of the invention are also provided. The invention also provides methods for detecting IRTA-2, as well as methods for treating various B cell malignancies, including non-Hodgkin's lymphoma. | 2008-10-09 |
20080247945 | ANTI-IL-20 ANTIBODIES AND BINDING PARTNERS AND METHODS OF USING IN INFLAMMATION - The present invention relates to blocking the activity of IL-20 polypeptide molecules. IL-20 is a cytokine that is involved in inflammatory processes and human disease. IL-20RA/IL-20RB is a common receptor for IL-20. The present invention includes anti-IL-20 antibodies and binding partners, as well as methods for antagonizing IL-20 using such antibodies and binding partners. | 2008-10-09 |
20080247946 | Gastrin Releasing Peptide Compounds - New and improved compounds for use in radiodiagnostic imaging or radiotherapy having the formula M-N—O—P-G, wherein M is the metal chelator (in the form complexed with a metal radionuclide or not), N—O—P is the linker, and G is the GRP receptor targeting peptide. Methods for imaging a patient and/or providing radiotherapy to a patient using the compounds of the invention are also provided. A method for preparing a diagnostic imaging agent from the compound is further provided. A method for preparing a radiotherapeutic agent is further provided. | 2008-10-09 |
20080247947 | High dose 111In-pentetreotide therapy of neuroendocrine tumors - A method for treating a neuroendocrine tumor is disclosed, which includes administering a first dose of | 2008-10-09 |
20080247948 | STEREOISOMERS OF FATTY ACID ANALOGS FOR DIAGNOSTIC IMAGING - The present invention provides novel imaging agents for clinical diagnosis of injuries and diseases, in the form of a radionuclide in spatial proximity to a substantially pure stereoisomer of a fatty acid analog. The invention also provides methods for using the novel imaging agents, and kits containing one or more of the novel imaging agents of the invention. | 2008-10-09 |
20080247949 | Biological Tissue Examination Agent Comprising Hemoglobin Labeled With Oxygen Isotope And Method For Producing The Same - The present invention relates to a biological tissue examination agent comprising hemoglobin labeled with | 2008-10-09 |
20080247950 | Activation of peptide prodrugs by hK2 - The invention provides novel peptide prodrugs that contain cleavage sites specifically cleaved by human kallikrein 2 (hK2). These prodrugs are useful for substantially inhibiting the non-specific toxicity of a variety of therapeutic drugs. Upon cleavage of the prodrug by hK2, the therapeutic drugs are activated and exert their toxicity. Methods for treating cell proliferative disorders are also featured in the invention. | 2008-10-09 |
20080247951 | ANTI-ROBO4 ANTIBODIES AND USES THEREFOR - The invention provides anti-Robo4 antibodies, and compositions comprising the antibodies and methods of using these antibodies, including diagnostic and therapeutic methods. | 2008-10-09 |
20080247952 | Method for Quantifying a Cholinergic Neurotoxin in a Sample - The invention relates to a method for determining the kinetics of action of a cholinergic neurotoxin as well as a method for determining the quantity of neurotoxin in a sample. | 2008-10-09 |
20080247953 | METHODS AND COMPOSITIONS FOR AFFECTING SUBSTRATE DOCKING OF KINASES IN MODULATING CELLULAR ACTIVITIES - The present invention relates to drug screening assays, therapeutic protocols and pharmaceutical compositions designed to target non-receptor tyrosine family kinases and components of the tyrosine kinase family signal transduction pathways. This includes primarily diseases or conditions associated with immune responses and can include treatment for cancers as well as various immune disorders. The invention reports a novel substrate SH2 domain docking mechanism apart from the kinase active site that is required for appropriate tyrosine phosphorylation by these tyrosine kinases. | 2008-10-09 |
20080247954 | Methods for the treatment of primary headache disorders using prostanoid EP4 receptor antagonists, and assays for agents for such treatment - The present invention provides for the treatment of primary headache disorders, particularly migraine, using antagonists of the EP | 2008-10-09 |
20080247955 | Inflammation treatment, detection and monitoring via TREM-1 - The present invention provides methods of treating inflammatory diseases/disorders in a subject by inhibiting/antagonizing TREM-1 expression/activity/signal transduction and/or DAP12/TyroBP expression and/or activity. Methods of detecting the presence of inflammatory disease in a subject by detecting TREM-1 and/or DAP12/TyroBP expression and/or activity in the subject or a sample obtained therefrom, wherein increased expression or activity is indicative of the inflammatory disease are also included. The present invention further provides methods for assessing the efficacy of a TREM-1-modulating agent administered to a patient by detecting levels of secreted phosphoprotein 1 (SPP1) and/or one or more other biomarkers in the patient or in a sample from the patient. | 2008-10-09 |
20080247956 | IDENTIFICATION OF NOVEL FACTORS THAT BLOCK PROGRAMMED CELL DEATH OR APOPTOSIS BY TARGETING JNK - Methods and compositions for modulating apoptosis by acting on the c-Jun-N-terminal kinase (JNK) pathway and assays for the isolation of agents capable of modulating apoptosis, including modulators of the JNK pathway are disclosed. A method of modulating JNK pathway independent of Gadd46β is disclosed. Methods and compositions are presented for the preparation and use of novel therapeutic compositions for modulating diseases and conditions associated with elevated or decreased apoptosis. | 2008-10-09 |
20080247957 | Advanced drug delivery strategy and platform for minimally-invasive treatment of liver cancer - The present invention comprises minimally invasive methods useful in the treatment of liver cancer. The method of the present invention comprises administering to an individual with liver cancer an injectable, echogenic nanocapsule and/or microcapsule wherein the nanocapsule and/or microcapsule comprises a therapeutic agent, a targeting moiety, or a combination thereof. The method of the present invention further comprises monitoring the distribution of the nanocapsule and/or microcapsule using ultrasound. The method of the invention delivers a therapeutic agent to a liver cancer cell either by biodegradation of a nanocapsule and/or microcapsule comprising a therapeutic agent, or by altering the biodegradation of a nanocapsule and/or microcapsule using ultrasound. | 2008-10-09 |
20080247958 | Albumin-based colloid composition having at least one protected thiol region, methods of making, and methods of use - A composition comprising an albumin-based colloid composition having at least one protected thiol region, method of making the same, and method for use, including treating hypovolemic conditions such as capillary leak syndrome and shock, are disclosed. The composition also is modified with an indicator reagent such as chromophores. | 2008-10-09 |
20080247959 | FORM OF ADMINISTRATION SECURED AGAINST MISUSE - The invention relates to a form of administration which is thermoformed without extrusion, comprising at least one synthetic or natural polymer having a resistance to breaking of at least 500 N in addition to one or several active ingredients with a misuse potential and, optionally physiologically compatible auxiliary substances. The invention also relates to a method for the production thereof. | 2008-10-09 |
20080247960 | Foaming Tropical Compositions - Improved aqueous foaming topical compositions for the application to the human body particularly to the skin which composition provides both a cleaning benefit, and a durable antimicrobial benefit. | 2008-10-09 |
20080247961 | NASALLY ADMINISTRABLE COMPOSITIONS OF ZOLPIDEM AND METHODS OF USE - The present invention provides a method for inducing sleep, by nasally administrating to a subject in need thereof a pharmaceutical composition containing zolpidem, a pharmaceutically acceptable salt thereof, or a combination thereof, and a pharmaceutically acceptable nasal carrier in liquid form. | 2008-10-09 |
20080247962 | Pharmaceutical Compositions Comprising Higher Primary Aliphatic Alcohols and Hmg Coa Reductase Inhibitor and Process of Preparation Thereof - A novel pharmaceutical composition comprising a mixture of higher primary aliphatic alcohols from (24) to (39) carbon atoms; at least one another component selected from resins and pigments, hydrocarbons, esters, ketones and aldehydes, and phenolic compounds, and HMG CoA reductase inhibitor, its salts, analogs or derivatives thereof, preferably statins, optionally with pharmaceutically acceptable excipients, and process of preparation of such composition is provided. Also provided are method of treatment and use of such composition for reducing abnormal lipid parameters associated with hyperlipidemia. | 2008-10-09 |
20080247963 | Quinuclidine Compounds Having Quaternary Ammonium Group, Its Preparation Method and Use as Blocking Agents of Acetylcholine - The invention relates to the quinuclidine compounds of formula I having quaternary ammonium group, its preparation, and the pharmaceutical composition comprising an effective amount of the compound of formula I. The compound and the composition are used to prevent and treat the diseases by blocking acetylcholine receptor. | 2008-10-09 |
20080247964 | SUBSTITUTED AZASPIRO DERIVATIVES - Substituted azaspiro derivatives of the Formula: | 2008-10-09 |
20080247965 | PRESSURISED METERED DOSE INHALERS (MDI) - The invention relates to pressurized metered dose inhalers (MDIs) in which all or part of the internal surface is lined with an inert organic coating and which contain a formulation which comprises TA 2005. | 2008-10-09 |
20080247966 | Compositions and Methods to Counteract Oral Malodour - The invention relates to hedonistically pleasing oral malodour counteracting compositions including flavour compositions and oral care products, methods to form such compositions and methods to counteract oral malodour. The compositions comprises 4 or more of oral malodour counteracting actives in a total concentration of at least 20% (w/w) based on the total concentration of flavour ingredients, and an individual concentration of 1% or more per oral malodour counteractant, based on total flavour ingredients. The maximum concentration of any individual oral malodour counteracting active based on the total of oral malodour counteracting actives is 70%. The identified oral malodour counteracting actives are various flavour compounds and natural ingredients. | 2008-10-09 |
20080247967 | Dentifrice with packaging layers - A dentifrice composition comprising at least one phase, wherein said dentifrice is packaged in a generally transparent container, and wherein the combination of the dentifrice and the container and/or at least one packaging layer forms a pattern. | 2008-10-09 |
20080247968 | Multi-phase dentifrice with characters - A multi-phase dentifrice composition comprising at least two visually distinct phases, wherein said visually distinct phases are packaged in a generally transparent container, wherein at least one phase is in physical contact with another phase, and wherein the visually distinct phases form the appearance of at least one character. | 2008-10-09 |
20080247969 | Opaque multi-phase dentifrice with patterns - A multi-phase dentifrice composition comprising at least two visually distinct phases wherein said visually distinct phases are packaged in a generally transparent container, wherein at least one phase is in physical contact with another phase, wherein all visually distinct phases are opaque, and wherein the visually distinct phases form any of a variety of patterns, excepting stripes. | 2008-10-09 |
20080247970 | Opaque multi-phase dentifrice with alternating bands - A multi-phase dentifrice composition comprising at least two visually distinct phases wherein said visually distinct phases are packaged in a generally transparent container, at least one phase is in physical contact with another phase, all visually distinct phases are opaque, and the visually distinct phases form alternating bands wherein at least one band is oriented in a direction not parallel to the longitudinal axis of the container or at least one band is oriented in a direction not parallel to the direction that the composition is dispensed from the container. | 2008-10-09 |
20080247971 | Transparent multi-phase dentifrice with coils - A multi-phase dentifrice composition comprising at least two visually distinct phases wherein said visually distinct phases are packaged in a generally transparent container, at least one phase is in physical contact with another phase, at least one visually distinct phase is generally transparent, and at least one visually distinct phase forms a coil through at least one other visually distinct phase. | 2008-10-09 |
20080247972 | Mouthwash for the Prevention and Treatment of Halitosis - The present aspects relate to a mouthwash developed to reduce and/or avoid the formation of tonsilloliths, heretofore unknown to the art, to facilitate the removal and to diminish the new formation of tongue coating and to reduce the concentration and formation of volatile sulfur compounds. In a preferred aspect, the compound includes Hydrogen peroxide, Citric acid, flavorizer, Sodium benzoate, Cetylpyridinium chloride, colorant, Sodium fluoride, Methyl paraben, Polisorbate 20 (Tween 20), Dimethicone, Sodium saccharine, Sorbitol and demineralized water. The compound may be used in mouth washing and gargling so that the active ingredients can be released. | 2008-10-09 |
20080247973 | Compositions and Methods for Improving Overall Tooth Health and Appearance - Disclosed are oral care compositions comprising selected surface-active organophosphate compounds and methods of use to provide protection of teeth from erosion caused by the action of chemicals, such as harsh abrasives and acids. The surface-active organophosphate compounds are substantive to teeth, the phosphate groups binding the calcium in teeth and thus preventing loss of calcium from dissolution when contacted with acids. The organophosphate compound may also deposit a protective surface coating that prevents contact of teeth with erosive challenges. Selected organophosphate compounds contain one or more phosphate groups and are combined in the oral care composition with one or more of a fluoride ion agent, an antimicrobial agent preferably selected from quaternary ammonium compounds and polyvalent metal salts, an anticalculus agent and additional surfactant, to provide benefits including superior anti-erosion, anticaries, antiplaque and anti-staining as demonstrated by enhanced fluoride uptake, remineralization, resistance to acid demineralization and antimicrobial activities, resulting in improved overall tooth health, structural integrity and appearance. | 2008-10-09 |
20080247974 | Rooibos Extract with Increased Aspalathin Content, Process for the Preparation of Such a Rooibos Extract , and Cosmetic Agent Containing Such a Rooibos Extract - The invention relates to a rooibos extract prepared from unfermented rooibos raw material by means of a solvent extraction, with an increased aspalathin content that is at least 5 wt %, cosmetic agents prepared from such a rooibos extract, and a process for the preparation of such a rooibos extract having an increased aspalathin content and preferably a reduced chlorophyll content. | 2008-10-09 |
20080247975 | Sunscreen and personal care compositions comprising a select copolymer - Topically applicable, water-resistant cosmetic or dermatological compositions well suited for the UV-photoprotection of human skin and/or hair comprising an effective UV— photoprotecting amount of: | 2008-10-09 |
20080247976 | Sunscreen and personal care compositions comprising a random terpolymer - Topically applicable, water-resistant cosmetic or dermatological compositions well suited for the UV-photoprotection of human skin and/or hair comprising an effective UV-photoprotecting amount of:
| 2008-10-09 |
20080247977 | Anhydrous Film for Lip Make-Up or Care - The invention concerns a cosmetic product for lip make-up or care in the form of an anhydrous film comprising: a) at least one water-soluble polymer, and b) at least one dye. Said anhydrous film dissolves in contact with saliva to provide lip make-up or treatment. | 2008-10-09 |
20080247978 | Underarm Products With Superabsorbent Component - A stick or soft solid suspension product comprising: (a) 0.01-20 weight % of a polyacrylate superabsorbent polymer (sodium salt), with a salt or ionic strength tolerance under a Baseline Absorption Test sufficient to give at least 25 weight % water absorption; (b) 10-88 weight % of a volatile silicone having a flash point of 100° C. or less; (c) a selected gelling agent; provided that the water content is ≦2 weight % and the ratio of superabsorber to active salt is in the range of 0.13-4:1. | 2008-10-09 |
20080247979 | Use of a Hydrophobic Zeolite, that Contains and Gives a Slow Release of an Active Element, for Treatment of Skin - The invention describes the use of a hydrophobic zeolite, that contains an active component, especially a disinfection element, as ethanol, iodine, phenol, cresol or hydrogen peroxide, in a composition for non-medical treatment of the skin, for example as a deodorant. The invention also describes the use of a hydrophobic zeolite, that contains an active component, especially a disinfection element, as ethanol, iodine, phenol, cresol or hydrogen peroxide, for manufacturing of a pharmaceutical preparation for treatment of skin related conditions and diseases, as skin infections. The hydrophobic zeolite is especially selected from that group that comprises silicalite, or hydrophobic ZMS-5, hydrophobic mordenite and hydrophobic zeolite Y. | 2008-10-09 |
20080247980 | Hair Care Compositions Comprising a Dendritic Polymer - A cosmetic and personal care composition comprising a hydrophobically functionalised polyhydric dendritic macro-molecule built up from polyester or polyether units or mixtures thereof. | 2008-10-09 |
20080247981 | Vinylpyrrolidone/Vinyl Acetate Copolymer, Process for Producing the Same, and Use of the Same - To provide a vinylpyrrolidone/vinyl acetate copolymer which is extremely reduced in thermal yellowing and is usable even at high temperatures and which can dissolve in water to give a transparent solution. The vinylpyrrolidone/vinyl acetate copolymer of the present invention has a residual vinylpyrrolidone content of 100 ppm or less relative to a solid content of the copolymer. A 5% by weight aqueous solution of the copolymer has an NTU value of 4.0 or less. A 50% aqueous solution of the copolymer has a Hazen color number (APHA) according to JIS-K3331 of 350 or less, the Hazen color number being measured by the following accelerated test. | 2008-10-09 |
20080247982 | Hair Treatment Product Containing Anionic and Cationic Surfactants - The invention relates to a hair treatment product containing a1) alkyl ether sulfate or a2) alkyl sulfate or the mixture thereof, b) secondary alkane sulfonate, c1) betaine or c2) ether carboxylate or the mixture thereof, d) at least one non-ionic surfactant, and e) a cationic surfactant. | 2008-10-09 |
20080247983 | HAIR POMADE COMPOSITION AND METHOD OF MAKING THE SAME - The method for making a hair pomade composition includes the steps of melting petroleum jelly over a heated surface and then mixing sesame seed oil, meadowfoam seed oil, pumpkin seed oil, Cyprus oil, basil sweet oil, Rosemary oil, black pepper oil, lemon oil, and Anise oil with the melted petroleum jelly into a mixture. Thereafter, the all-natural hair pomade mixture is solidified. | 2008-10-09 |
20080247984 | DOPA-FUNCTIONALIZED, BRANCHED, POLY(AKLYLENE OXIDE) ADHESIVES - The invention describes DOPA functionalized, branched, polyalkylene oxide materials that are useful as adhesives. | 2008-10-09 |
20080247985 | Composition base containing solubilized allantoin and urea for topical preparations - Substantially homogeneous topical preparations for cosmetic, veterinary, and pharmaceutical use comprise at least one active ingredient solubilized in a novel composition base. The composition base comprises solubilized allantoin at a level of at least 0.5% and urea at a level of at least 10% in an aqueous vehicle. | 2008-10-09 |
20080247986 | Hyaluronidase Inhibitor Containing Poly-Gamma-Glutamic Acid as an Effective Component - The present invention relates to a hyaluronidase inhibitor containing poly-gamma-glutamic acid (PGA) as an active ingredient, a composition for maintaining skin elasticity and a composition for improving allergy, wherein each of the compositions contains PGA as an active ingredient. The inventive compositions containing PGA are effective in maintaining skin moisturization and skin elasticity by effectively inhibiting the activity of hyaluronidase which is an enzyme that degrades hyaluronic acid present in the skin dermis. Also, the compositions can relieve allergic symptoms by inhibiting the permeability of inflammatory cells. | 2008-10-09 |
20080247987 | Block Copolymer Compositions and Uses Thereof - The present invention describes compositions, devices, and methods for the production, use and administration of the composition having a non-thermoreversible block copolymer composition. | 2008-10-09 |
20080247988 | METHODS OF MAKING AND USING SURFACTANT POLYMERS - Comblike, surfactant polymers for changing the surface properties of biomaterials are provided. Such surfactant polymers comprise a polymeric backbone of repeating monomeric units having functional groups for coupling with side chains, a plurality of hydrophobic side chains linked to said backbone via the functional groups, and a plurality of hydrophilic side chains linked to said backbone via the functional groups. The hydrophobic side chains comprise an alkyl group comprising from 2 to 18 methylene groups. The alkyl groups are linked to the polymeric backbone through ester linkages, secondary amine linkages, or, preferably, amide linkages. The hydrophilic side chain is selected from the group consisting of: a neutral oligosaccharide, which, preferably, has weight average molecular weight of less than 7000; a charged oligosaccharide, preferably a negatively charged oligosaccharide having a weight average molecular weight of less than 10,000; an oligopeptide of from about 3 to about 30 amino acid residues, said oligopeptide having an amino acid sequence which interacts with protein receptors on the surface of cells; and combinations thereof. Methods of making the surfactant polymers and using the surfactant polymers to alter the surface properties of a biomaterial are also provided. | 2008-10-09 |
20080247989 | Reishi - Mediated Enhancement of Human Tissue Progenitor Cell Adhesion and Differentiation - The present disclosure provides medicinally active extracts and fractions, and methods for using the same to increase eukaryotic cell adhesion, to increase differentiation of eukaryotic cells to produce increased numbers of B cells dendritic cells and chodrocytes, and to maintain undifferentiated hematopoietic cells. These methods and useful for modulating immune response, modulating hematopoietic activity, and engineering certain types of eukaryotic tissues. | 2008-10-09 |
20080247990 | GENETICALLY MODIFIED HUMAN NATURAL KILLER CELL LINES - The invention provides a natural killer cell, NK-92, modified to express a CD16 receptor or an inhibitory killer cell immunoglobulin-like receptor (KIR) on a surface of the cell. In examples, the NK-92 cell is further modified to co-express an associated accessory signaling protein such as FcεRI-γ or TCR-ζ, chemokines, or cytokines such as interleukin-2 (IL-2) or interleukin-15 (IL-15). Additional methods are disclosed for various assays, assessments, and therapeutic treatments with the modified NK-92 cells. | 2008-10-09 |
20080247991 | Solution Additives For the Attenuation of Protein Aggregation - In part, the present invention relates to a compound or polymer comprising a non-protein-binding moiety and at least one protein-binding group. The present invention relates to a method of screening compounds or polymers for the property of inhibiting protein aggregation in solution, a method of preparing a compound or polymer having the property of protein aggregation inhibition in solution, a method of classifying a compound or polymer as either inhibitory of protein aggregation in solution or not inhibitory of protein aggregation in solution, and to a method of determining the preferential binding coefficient, Γ | 2008-10-09 |
20080247992 | NITROGEN-CONTAINING HETEROARYL DERIVATIVES - Disclosed are compounds, compositions and methods for treating Flaviviridae family virus infections. | 2008-10-09 |
20080247993 | Microorganisms Inhibiting the Formation of Axillary Malodor - Described are microorganisms which are able to suppress the production of malodorous compounds by axillary bacteria. Also described are compositions comprising such microorganisms as well as the use of such micoorganisms in cosmetic, prophylactic or therapeutic applications. | 2008-10-09 |
20080247994 | DNA vaccine - The present invention relates to a DNA vaccine consisting of a vector expressing a part or the whole of a polypeptide regulating production of an inflammatory cytokine, a pharmaceutical composition comprising the DNA vaccine, and a method of preventing or treating an inflammatory disease by using the pharmaceutical composition. | 2008-10-09 |
20080247995 | Wound and cutaneous injury healing with a nucleic acid encoding a proteoglycan polypeptide - The present disclosure provides nucleic acid constructs encoding one or more polypeptides containing at least one glycosaminoglycan chain, such as, but not limited to, a proteoglycan polypeptide, and methods for delivering to the site of a wound or cutaneous injury at least one nucleic acid construct encoding one or more such polypeptides, such that the expressed polypeptide is glycated by glycosaminoglycan chains through the normal physiological processes of the subject at the site of administration to produce a functional proteoglycan polypeptide for the healing of the wound or other cutaneous injury. The delivered nucleic acid construct is transcribed, translated and post-translationally modified by the addition of glycosaminoglycan chains (referred herein as “decoration” or “glycation”) to produce a decorated polypeptide. The decorated polypeptide is then secreted from the cell in which it was produced to provide treatment of wounds and/or cutaneous injury in the subject and/or prevention of cutaneous injury in a subject. | 2008-10-09 |
20080247996 | Methods of treating neoplasia with combination target cell-specific adenovirus, chemotherapy and radiation - The invention provides methods of treating neoplasia using combinations of target cell-specific replication competent adenoviral vectors and chemotherapy, radiation therapy or combinations thereof. The adenoviral vectors are target cell-specific for the particular type of neoplasia for which treatment is necessary and the combination with the chemotherapy and/or radiation leads to synergistic treatment over existing adenoviral therapy or traditional chemotherapy and radiation therapy. | 2008-10-09 |
20080247997 | EXTERNAL ANIMAL LAYER SANITATION USING BACTERIOPHAGE - Methods for disinfecting external layers from animals include applying phage to the external layers. Phage may be applied before an external layer is removed from a remainder of an animal's body, during the removal process, or following removal of the external layer from the remainder of the animal's body. | 2008-10-09 |
20080247998 | Creation of a Biological Atrioventricular Bypass to Compensate for Atrioventricular Block - A method of creating an atrioventricular bypass tract for a heart comprises growing mesenchymal stem cells into a strip with two ends, attaching one end of the strip onto the atrium of the heart, and attaching the other end of the strip to the ventricle of the heart, to create a tract connecting the atrium to the ventricle to provide a path for electrical signals generated by the sinus node to propagate across the tract and excite the ventricle. | 2008-10-09 |
20080247999 | Treating Cancer - The present invention provides a peptide comprising an amino acid sequence that is part of the amino acid sequence of CDK4 protein, or homologous to part of the amino acid sequence of CDK4 protein, which peptide is cytotoxic to, and/or inhibiting to the growth of, a cancer cell and/or stimulating to the growth of a non-cancerous cell and/or a control cell. Methods of identifying such peptides and medical uses of such peptides are also disclosed. | 2008-10-09 |
20080248000 | Stem Cells, Method For Their Purification, Identification, and Use - Herein is described a new population of circulating CD14+cells, with a low density surface expression of CD34 and endowed with stem capacity, a method for their purification and identification, and their therapeutic use. | 2008-10-09 |